How to Buy Sanara Medtech Stock
Sanara Medtech Inc
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States.
Sanara Medtech stock last closed at $28.66, down 2.62% from the previous day, and has decreased 12.89% in one year. It has underperformed other stocks in the Medical Instruments & Supplies industry by 0 percentage points. Sanara Medtech stock is currently +10.83% from its 52-week low of $25.86, and -26.66% from its 52-week high of $39.08.
As of Apr 21, 2025, there are 8.9M shares of SMTI outstanding. The market capitalization of SMTI is $255.13M. In the last 24 hours, 9860 SMTI shares were traded.
How to Buy Sanara Medtech Stock
Wondering how to invest in Sanara Medtech stock? Here's how.
- Figure out where to buy Sanara Medtech stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Sanara Medtech stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your method of payment and add your info.
- Analyze Sanara Medtech stock: The Sanara Medtech ticker symbol is SMTI. Is Sanara Medtech stock a good investment? Should you buy shares of SMTI? How do SMTI's underlying business fundamentals look? Do top analysts think Sanara Medtech is a good buy? Why has SMTI's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if SMTI is a good stock to buy).
- Execute your SMTI purchase: Decide if you will purchase SMTI shares at the current market price or use a limit order to purchase SMTI stock at a particular price.
- Get updates on your investment in SMTI: Create a watchlist to get live updates on your position in Sanara Medtech stock.
Step 1: Figure out where to buy Sanara Medtech stock
You need an online brokerage account in order to access the NASDAQ market and buy SMTI stock.
Our recommended brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Technology to Real Estate, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal info so you are able to invest in SMTI stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Send your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've opened your account on the stocks app, you can securely and quickly fund your account:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Analyze Sanara Medtech stock
After you have figured out the best place to buy Sanara Medtech stock, it's very important to analyze their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Sanara Medtech shares quick numbers
Fundamentals of Sanara Medtech
WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SMTI's stock page.
Is SMTI stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge SMTI's intrinsic value.
Using relative valuations ratios:
- SMTI may be overvalued based on its P/B ratio of 6.47x, relative to Medical Instruments & Supplies industry P/B ratio of 3.49x
You can do more valuation research on SMTI's stock here.
SMTI Financial Health
Passed Financial Due Diligence Checks:
- SMTI has cash burn of 229632. It has enough cash and short-term investments to cover this for at least one year.
- SMTI has $16.98M in cash and short term investments. This is sufficient to cover its annual cash burn of $229.63k.
- There are more short-term assets than short-term liabilities on the SMTI balance sheet.
Failed Financial Due Diligence Checks:
- There are more long-term liabilities than short-term assets on the SMTI balance sheet.
- Total SMTI debt is higher than 5 years ago, relative to shareholder equity.
- SMTI has a relatively high debt to equity ratio of 1.25.
- SMTI profit margin has gone down from -6.6% to -11.2% in the past year.
Do analysts think it's a good time to buy SMTI stock
Out of 2 Wall Street analysts who give ratings on SMTI, the consensus analyst rating on Sanara Medtech is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Sanara Medtech stock forecast page.
Metrics for Advanced SMTI Traders
SMTI Growth Metrics
Last year, SMTI revenue was $86.67M. In the past five year, SMTI's revenue has increased by 49.09% per year. This was faster than the Medical Instruments & Supplies industry average of 8.96%.
Dive into SMTI's earnings and revenue performance here.
Are SMTI executives and large shareholders buying or selling the stock?
Over the past 12 months, executives and large shareholders at SMTI have sold more shares than they have bought.
Jacob A. Waldrop, Chief Operating Officer of SMTI, was the latest SMTI insider to sell. They sold $11,105.64 worth of SMTI stock on Apr 15, 2025.
Get more info about who owns SMTI shares here.
Does SMTI provide a stable income stream?
No, Sanara Medtech doesn't provide an income stream by paying out dividends.
What others are saying about SMTI
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your SMTI purchase
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price, use a limit order.
Click the Open button and your broker will execute your order.
If you want additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your investment in SMTI
Now that you own some SMTI stock, you'll want to stay up-to-date on your new investment.
Create a watchlist to monitor your SMTI stock.
SMTI Feed
No news
There is no news on the companies in your watchlist or you don't have enough companies added to your list.
How to Buy Stock in Sanara Medtech
To summarize, here are the 6 steps you need to take to buy Sanara Medtech stock right now:
- Figure out where to buy Sanara Medtech stock
- Open a brokerage account
- Deposit funds into your brokerage account
- Analyze Sanara Medtech stock
- Execute your SMTI purchase
- Get updates on your investment in SMTI
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Sanara Medtech, click below.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.